FEDERICO, VINCENZO
FEDERICO, VINCENZO
BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels.
2008 Libotte, F; Ricciardi, Maria Rosaria; Calabrese, E; De Benedictis, C; Santinelli, S; Bergamo, P; Decandia, S; Levi, A; Mohamad, Af; Federico, Vincenzo; Milella, M; Foà, R; Tafuri, Agostino; Petrucci, M. T.
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
2012 Gregorio Antonio Brunetti, ; Federico, Vincenzo; Fabio, Efficace; Grammatico, Sara; Andrea, Tendas; Laura, Scaramucci; Luca, Cupelli; Gianna Maria D'Elia, ; Truini, Andrea; Pasquale, Niscola; Maria Teresa Petrucci,
Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.
2013 Petrucci, Mt; Calabrese, E; Levi, Anna; Federico, Vincenzo; Ceccolini, M; Rizzi, R; Gozzetti, A; Falco, P; Lazzaro, C; Martelli, E; Boccadoro, M; Lauria, F; Liso, V; Cavo, M; Foa, Roberto
Functional effects of the bcl-2/bcl-xl inhibitor abt-737 on primary cells from smoldering and symptomatic multiple myeloma.
2008 Libotte, F; Ricciardi, Maria Rosaria; Calabrese, E; Santinelli, S; Bergamo, P; Decandia, S; De Cave, F; Gregorj, Chiara; Federico, Vincenzo; Milella, M; Foà, R; Tafuri, Agostino; Petrucci, M. T.
Simultaneous inhibition of the Raf/MEK/ERK and Bcl-2 pathways results in strikingly synergistic induction of apoptosis in multiple myeloma cells.
2008 Ricciardi, Maria Rosaria; Libotte, F; Calabrese, E; Bergamo, P; Santinelli, S; Decandia, S; Federico, Vincenzo; Foà, R; Tafuri, Agostino; Milella, M; Petrucci, M. T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels. | 2008 | Libotte, F; Ricciardi, Maria Rosaria; Calabrese, E; De Benedictis, C; Santinelli, S; Bergamo, P; Decandia, S; Levi, A; Mohamad, Af; Federico, Vincenzo; Milella, M; Foà, R; Tafuri, Agostino; Petrucci, M. T. | |
| Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma | 2012 | Gregorio Antonio Brunetti, ; Federico, Vincenzo; Fabio, Efficace; Grammatico, Sara; Andrea, Tendas; Laura, Scaramucci; Luca, Cupelli; Gianna Maria D'Elia, ; Truini, Andrea; Pasquale, Niscola; Maria Teresa Petrucci, | |
| Cost of illness in patients with multiple myeloma in Italy: the CoMiM study. | 2013 | Petrucci, Mt; Calabrese, E; Levi, Anna; Federico, Vincenzo; Ceccolini, M; Rizzi, R; Gozzetti, A; Falco, P; Lazzaro, C; Martelli, E; Boccadoro, M; Lauria, F; Liso, V; Cavo, M; Foa, Roberto | |
| Functional effects of the bcl-2/bcl-xl inhibitor abt-737 on primary cells from smoldering and symptomatic multiple myeloma. | 2008 | Libotte, F; Ricciardi, Maria Rosaria; Calabrese, E; Santinelli, S; Bergamo, P; Decandia, S; De Cave, F; Gregorj, Chiara; Federico, Vincenzo; Milella, M; Foà, R; Tafuri, Agostino; Petrucci, M. T. | |
| Simultaneous inhibition of the Raf/MEK/ERK and Bcl-2 pathways results in strikingly synergistic induction of apoptosis in multiple myeloma cells. | 2008 | Ricciardi, Maria Rosaria; Libotte, F; Calabrese, E; Bergamo, P; Santinelli, S; Decandia, S; Federico, Vincenzo; Foà, R; Tafuri, Agostino; Milella, M; Petrucci, M. T. |